How to Start Prescribing Peptides: A Physician's Complete Guide

Peptide therapy is entering mainstream medicine. With the FDA's recent reclassification of peptides from Category 2 to Category 1, hundreds of physicians are exploring how to integrate these therapeutics into their practice. This guide provides a practical roadmap for prescribing peptides legally, safely, and effectively.

Why Peptide Therapy Is Entering Mainstream Medicine

For the past decade, peptide therapy has existed in a regulatory gray area. Physicians prescribed them off-label through compounding pharmacies, patients reported dramatic results, and the FDA largely looked the other way. That changed in March 2024 when the FDA announced it would begin reclassifying peptides from Category 2 (currently marketed as bulk drug substances) to Category 1 (will not be used in compounding).

This reclassification created urgency. Physicians who had been considering peptides now face a closing window. Once a peptide moves to Category 1, it can no longer be compounded unless the pharmacy demonstrates clinical need through the 503A exemption process. Some peptides (BPC-157 and TB-500, for example) may remain accessible. Others may not.

The result: a sharp increase in physician interest. Peptides offer therapeutic options for conditions that conventional medicine struggles to address: chronic inflammation, tissue repair, immune dysfunction, metabolic decline, and cognitive aging. Many of these peptides have decades of research behind them, even if they lack FDA approval as standalone drugs.

The regulatory environment is still evolving. The FDA's proposed timeline has faced delays, and industry groups continue to challenge the reclassification. But the direction is clear: peptide prescribing will become more regulated. Physicians who establish compliant practices now will be better positioned as rules solidify.

Which Peptides Can Be Legally Prescribed Today

Not all peptides are created equal from a regulatory standpoint. The FDA evaluates each peptide individually based on safety data, marketing history, and whether an FDA-approved alternative exists. Here are the peptides most commonly prescribed through compounding pharmacies in 2026:

BPC-157 is the most widely prescribed peptide for tissue repair. Originally derived from gastric juice, it's been studied for tendon healing, inflammatory bowel disease, and joint recovery. Most physicians prescribe 250-500 mcg subcutaneously once or twice daily. Research is largely preclinical, but anecdotal reports from patients are consistently positive.

Sermorelin stimulates endogenous growth hormone release. Unlike synthetic HGH, it works through the body's natural pulsatile secretion. This makes it safer for long-term use and less likely to suppress natural production. Typical dosing is 200-500 mcg before bed. It's often stacked with Ipamorelin for synergistic effect.

TB-500 promotes angiogenesis and tissue regeneration. It's commonly used for muscle strains, ligament injuries, and post-surgical recovery. Dosing varies: loading phases use 5-10 mg twice weekly, followed by maintenance at 2-5 mg weekly. It's often combined with BPC-157 for musculoskeletal injuries.

Thymosin Alpha-1 is FDA-approved in over 30 countries for immune enhancement but remains off-label in the U.S. It's used for chronic viral infections (hepatitis B/C, Lyme), cancer immunotherapy support, and immune senescence. Standard dosing is 1.6 mg subcutaneously twice weekly.

The key legal principle: peptides can be prescribed if they're being compounded for an individual patient based on a valid physician-patient relationship. This means telemedicine-only prescribing may not meet the standard in all states. Know your state's prescribing rules.

Choosing a Compounding Pharmacy

Your compounding pharmacy is your most important partner in peptide prescribing. A good pharmacy ensures quality, consistency, and compliance. A bad one puts your license at risk. Here's what separates them.

503A vs 503B Pharmacies

503A pharmacies compound patient-specific prescriptions. They operate under state pharmacy boards and can ship across state lines if properly licensed. They're not required to follow current Good Manufacturing Practices (cGMP) but must follow USP standards. Most peptide prescriptions go through 503A pharmacies.

503B outsourcing facilities produce larger batches under FDA oversight and cGMP standards. They can produce without patient-specific prescriptions but face stricter regulations. They're generally used for office-based dispensing or higher-volume practices.

For most physicians starting out, 503A pharmacies are the right choice. They offer flexibility, lower minimums, and direct patient shipping.

What to Look for in a Peptide Pharmacy

Red flags: pharmacies that won't share COAs, have recent FDA warning letters, offer prices significantly below market, or push aggressive marketing. Quality peptides cost money to produce. If a pharmacy's prices seem too good to be true, they probably are.

Ask other physicians. The best pharmacies build reputations through word-of-mouth. Local medical societies and online physician communities are valuable resources for pharmacy recommendations.

Basic Protocol Structure

Prescribing peptides isn't drastically different from prescribing other off-label medications. You need a documented medical rationale, informed consent, appropriate monitoring, and follow-up. Here's a basic framework.

1. Initial Consultation

Establish a physician-patient relationship. This should be a real clinical encounter: history, exam (even if virtual), discussion of symptoms and goals. Document the chief complaint and why conventional treatments have been inadequate or unsuitable.

Example: A 45-year-old male with chronic Achilles tendinopathy, failed conservative management (PT, NSAIDs, rest), wants to avoid surgery. BPC-157 + TB-500 becomes a reasonable therapeutic trial.

2. Baseline Labs

Peptides are generally well-tolerated, but baseline labs establish safety and help track progress. Recommended baseline labs vary by peptide:

• Growth hormone peptides (Sermorelin, CJC/Ipamorelin): IGF-1, fasting glucose, HbA1c, lipid panel
• Immune peptides (Thymosin Alpha-1): CBC with differential, comprehensive metabolic panel, relevant viral markers
• Tissue repair peptides (BPC-157, TB-500): Often none required unless underlying conditions warrant
• Metabolic peptides (NAD+): Liver function tests, comprehensive metabolic panel

3. Dosing and Administration

Most peptides are administered subcutaneously. Patients self-inject using insulin syringes, typically in the abdomen or thigh. Proper patient education is critical: injection technique, storage (most require refrigeration), and reconstitution if using lyophilized powder.

Start low, go slow. Even though peptides are generally safe, individual responses vary. A conservative starting dose allows you to assess tolerance before escalating.

Example BPC-157 protocol:

• Week 1-2: 250 mcg once daily, morning
• Week 3-8: 250 mcg twice daily (morning and evening)
• Reassess at 8 weeks; continue if beneficial, taper if resolved

4. Monitoring and Follow-Up

Schedule follow-up based on the peptide and indication. Growth hormone peptides warrant more frequent monitoring (every 3 months) with repeat IGF-1 levels. Tissue repair peptides can be monitored clinically: symptom tracking, functional improvement, imaging if indicated.

Document everything. Progress notes should reflect clinical rationale, patient response, any adverse effects, and your decision-making for continuing or adjusting therapy.

5. Duration of Therapy

Peptides are not meant to be lifelong therapies in most cases. Tissue repair peptides are typically used for 6-12 weeks. Growth hormone peptides may be used cyclically (3-6 months on, 1-2 months off). Immune peptides vary based on indication.

Avoid the "kitchen sink" approach. Stacking multiple peptides increases cost, complexity, and potential for interactions. Start with one or two targeted peptides, assess response, then consider adding others if needed.

Compliance Essentials

Peptide prescribing is legal, but it's not unregulated. The FDA's increased scrutiny means compliance matters more than ever. Here are the non-negotiables.

Informed Consent

Patients must understand they're receiving a compounded medication that is not FDA-approved. Your informed consent should cover:

• The peptide is compounded and not FDA-approved
• Known risks and potential side effects
• Alternative treatments (including FDA-approved options)
• Expected benefits and realistic timelines
• Cost (usually not covered by insurance)
• The experimental nature of the therapy

Document the consent conversation in your notes, not just a signed form. If questioned, you need to show the patient made an informed decision.

State Prescribing Rules

Telemedicine prescribing rules vary by state. Some states require an in-person exam before prescribing controlled or high-risk medications. Peptides aren't controlled substances, but some state boards have issued guidance on compounded medications.

Check your state medical board's position on telemedicine prescribing and compounded medications. If you're prescribing across state lines, ensure you're licensed in the patient's state and the pharmacy is licensed to ship there.

Documentation Requirements

Your medical records should demonstrate:

• A valid physician-patient relationship
• Clinical rationale for the peptide prescription
• Why FDA-approved alternatives are unsuitable
• Informed consent discussion
• Monitoring plan and follow-up schedule
• Patient response and clinical outcomes

Avoid cookie-cutter documentation. Each patient's record should reflect individualized decision-making. If your notes look identical for every BPC-157 prescription, you're doing it wrong.

Avoiding "Pill Mill" Perception

The FDA is particularly concerned about clinics that prescribe peptides without adequate oversight. To avoid scrutiny:

• Don't prescribe on the first encounter without establishing medical necessity
• Don't prescribe to patients you've never interacted with (e.g., bulk orders)
• Don't advertise peptides as performance enhancers or anti-aging miracles
• Don't prescribe outside your scope of practice
• Don't work with pharmacies that have FDA warning letters

Peptide prescribing should look like medicine, not a side hustle.

Getting Started Checklist

If you're ready to integrate peptides into your practice, here's your action plan:

1. Educate yourself. Read the research. Peptides like BPC-157 and TB-500 have extensive preclinical data. Familiarize yourself with dosing, mechanisms, and safety profiles. Organizations like A4M (American Academy of Anti-Aging Medicine) offer peptide courses.
2. Choose your pharmacy partner. Interview 2-3 compounding pharmacies. Ask for references from other physicians. Request sample COAs. Verify accreditation. Don't default to the cheapest option.
3. Develop your protocols. Start with 2-3 peptides you understand well. Create templated protocols (dosing, monitoring, follow-up) but customize for each patient. Document your clinical rationale.
4. Create compliant workflows. Draft informed consent forms. Build EMR templates for peptide visits. Train staff on patient education (injection technique, storage, reconstitution).
5. Start small. Prescribe to patients you know well, with clear indications. Track outcomes meticulously. Build confidence before scaling.
6. Join a physician community. Peptide prescribing is evolving rapidly. Connect with other physicians doing this work. Share experiences, protocols, and pharmacy recommendations.
7. Stay updated on regulations. The FDA's peptide policy is still in flux. Subscribe to industry newsletters (Peptide Society, A4M, compounding pharmacy updates). Be ready to adapt.

The Short Version

Peptide therapy offers real therapeutic options: targeted tissue repair, immune modulation, metabolic optimization. But these are still compounded medications without FDA approval, and they're not without risk.

The physicians who succeed with peptides treat them seriously. Rigorous patient selection, proper monitoring, transparent informed consent, quality pharmacy partners. The regulatory landscape will continue to tighten, and the ones who build compliant practices now will be positioned to keep offering these therapies as rules evolve.

If you're looking for a reliable pharmacy partner to get started, Conviction Labs has vetted relationships with accredited 503A and 503B facilities. We help physicians integrate peptides into their practice with compliant workflows, clinical support, and transparent pricing.

Schedule a call to learn how we support physicians prescribing peptides.